Signal Advisors Wealth »

United Therapeutics Corporation shares owned by Signal Advisors Wealth

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Signal Advisors Wealth from 13F filings

Historical chart of Signal Advisors Wealth investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Signal Advisors Wealth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Signal Advisors Wealth

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.1M 2.6k 419.21
2025-06-30 $1.5M 5.3k 287.35

More positions owned by Signal Advisors Wealth

Spdr Series Trust Portfolio S&p500 (SPLG)
Etf Ser Solutions Aptus Collrd Inv (ACIO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Bny Mellon Etf Trust Core Bond Etf (BKAG)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Etf Ser Solutions Aptus Defined (DRSK)
Microsoft Corporation (MSFT)
Apple (AAPL)
Pacer Fds Tr Swan Sos Fd Of (PSFF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Amazon (AMZN)
Etf Ser Solutions Aptus Drawdown (ADME)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Etf Ser Solutions Aptus Enhanced (JUCY)

View all positions for Signal Advisors Wealth

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation